Skip to main content
Clinical Trials/NCT02306980
NCT02306980
Completed
Not Applicable

Oral Administration of Colostrum to Premature Babies: Impact on the Oral Microbiota

University of California, Davis1 site in 1 country12 target enrollmentOctober 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Changes in the Oral Microbiota
Sponsor
University of California, Davis
Enrollment
12
Locations
1
Primary Endpoint
Oral microbiota
Status
Completed
Last Updated
8 years ago

Overview

Brief Summary

Oropharyngeal administration of mother's colostrum to premature infants has been proposed as a stimulus to the oropharyngeal lymphatic tissues to decrease the incidence of pneumonia and sepsis, particularly in intubated babies. We propose to study the impact of this intervention on the composition of the oral microbiota.

Registry
clinicaltrials.gov
Start Date
October 2013
End Date
June 2016
Last Updated
8 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • premature infant with birth weight \< 1500
  • intubated in the first 48 hours of life
  • available maternal colostrum

Exclusion Criteria

  • lethal condition

Outcomes

Primary Outcomes

Oral microbiota

Time Frame: Difference between enrollment, 48 hours and 96 hours

Changes in the composition of the community of microbes inhabiting the oral-cavity after administration of oropharyngeal maternal colostrum.

Study Sites (1)

Loading locations...

Similar Trials